Skip to main content
. 2020 Mar;70:102282. doi: 10.1016/j.jhealeco.2019.102282

Table 2.

Health effects of intervention at coverage level included at.

Allowing for different coverage levels
Allowing for different coverage levels (equity weighted)
All or nothing
Intervention ICER at coverage level Coverage level DALYs averted Equity weighted DALYs averted Equity weighted ICER at coverage level Coverage level DALYs averted Equity weighted DALYs averted ICER at coverage level Coverage level DALYs averted Equity weighted DALYs averted
Community newborn care package 108 100% 595 833 58 100% 595 833 80 95% 565 714
Tetanus toxoid 686 100% 9,925 13,895 224 100% 9,925 13,895 163 95% 9,429 11,910
Screening and treatment of syphilis 776 60% 321 321 776 60% 321 321 954 95% 509 643
Normal delivery by a skilled attendant 674 100% 4,998 6,998 271 100% 4,998 6,998 358 95% 4,748 5,998
Management of maternal sepsis 1,153 65% 82 82 900 58% 70 70
Management of serious newborn infections 1,072 75% 46 46 684 100% 62 87 555 95% 59 74
Measles rubella vaccine 1,097 85% 4,192 4,373 552 100% 4,661 5,912 380 95% 4,517 5,336
Insecticide-treated bed nets (ITN) 387 100% 10,706 13,903 210 100% 10,706 13,903 269 95% 10,328 12,391
Intermittent presumptive treatment in pregnancy (IPTP) 1,077 100% 141 189 355 100% 141 189 306 95% 135 166
Case management of malaria with artemisinin-based combination therapy (ACT) 44 100% 154,460 205,147 15 100% 154,460 205,147 17 95% 148,346 180,692
Treatment of new smear-positive TB cases only under DOTS 175 100% 15,402 21,563 64 100% 15,402 21,563 70 95% 14,632 18,482
Vitamin A supplementation in pregnant women 976 50% 863 863
Management of severe malnutrition (children)
Vitamin A supplementation in infants and children 6–59 months
Pneumonia treatment (children) 1,164 75% 3,035 3,035 827 65% 2,643 2,643 721 95% 3,863 4,880
Zinc 1,092 70% 870 870 708 100% 1,243 1,740 961 31% 385 486
Total 205,636 272,117 205,227 273,300 197,516 241,771
Maximum ICER 1,164 900 961